Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
114,150,925
-
Total 13F shares
-
35,179,105
-
Share change
-
-7,064,114
-
Total reported value
-
$96,742,719
-
Price per share
-
$2.75
-
Number of holders
-
113
-
Value change
-
-$20,013,129
-
Number of buys
-
53
-
Number of sells
-
45
Institutional Holders of Perspective Therapeutics, Inc. - Common Stock, $0.001 par value (CATX) as of Q4 2025
As of 31 Dec 2025,
Perspective Therapeutics, Inc. - Common Stock, $0.001 par value (CATX) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,179,105 shares.
The largest 10 holders included
BlackRock, Inc., MORGAN STANLEY, VANGUARD GROUP INC, Avidity Partners Management LP, Nicholson Wealth Management Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Nuveen, LLC, TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This page lists
113
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.